John, King of England succession. Henry the Young King had been crowned King of England in 1170, but was not given any formal powers by his father; he was also promised Normandy and Anjou as part of his future inheritance. Richard was to be appointed the Count of Poitou with control of Aquitaine, whilst Geoffrey was to become the Duke of Brittany. At this time it seemed unlikely that John would ever inherit substantial lands, and he was jokingly nicknamed "Lackland" by his father. Henry II wanted to secure the southern borders of Aquitaine and decided to betroth his youngest son to Alais, the
King Pharmaceuticals Inc. was incorporated in the State of Tennessee in 1993. According to the King Pharmaceutcals, Inc. Form 10-K for the year ended December 31, 2007 filed with the U.S. Securities and Exchange Commission, the wholly owned subsidiaries of King Pharmaceuticals, Inc. are Monarch Pharmaceuticals, Inc.; King Pharmaceuticals Research and Development, Inc.; Meridian Medical Technologies, Inc.; Parkedale Pharmaceuticals, Inc.; King Pharmaceuticals Canada Inc.; and Monarch Pharmaceuticals Ireland Limited. King Pharmaceuticals was founded in 1993 John M. Gregory, Randal J. Kirk, Joseph "Joe" R. Gregory, Jefferson "Jeff" J. Gregory, and James E. Gregory. In January 1994, King acquired a former King College